New Delhi, May 4 -- Small-cap pharma stock Sudarshan Pharma Industries share price jumped 4% on Monday, 4 May, after Q4 results, with both profit and revenue showing robust growth.

Net profit for the March 2026 quarter rose 44.8% to Rs.10.73 crore, compared with Rs.7.41 crore in the same period last year. Revenue for the quarter increased 36.72% to Rs.220.92 crore, up from Rs.161.59 crore year-on-year.

For the full financial year, net profit surged 55.64% to Rs.23.30 crore from Rs.14.97 crore in the previous year. Annual sales climbed 39.21% to Rs.703.06 crore, compared with Rs.505.04 crore in the preceding fiscal.

The company's results reflect strong operational momentum, with healthy growth across both quarterly and annual performanc...